SERT immunostaining pathology, consistent with the <sup>123</sup>I-FP-CIT SPECT findings, demonstrated a significant decrease in SERT expression in the substantia nigra and a significant increase in the pontine raphe nucleus in patients with MSA-P. The gene discussed is SLC6A4; the disease is multiple system atrophy.